You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

康宁杰瑞制药(09966.HK)四项新药临床试验申请获批

阿思达克 02-20 08:26
康宁杰瑞制药(09966.HK)公布，集团针对程式性死亡配体/细胞毒性淋巴细胞相关蛋白4(「PD-L1/CTLA-4」)双特异性抗体及人表皮生长因数受体2(「HER2」)双特异性抗体的四项新药临床试验申请，近日已获中国国家药品监督管理局药品审评中心受理。(sw/w)~ 阿思达克财经新闻 网址: www.aastocks.com
Relevant Recommendation
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.